Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis

ImportanceImmune checkpoint inhibitors (ICIs) have become the standard treatment for advanced non-small cell lung cancer (NSCLC). However, their prognostic role in NSCLC patients remains controversial. Hypertension (HTN) is an important risk factor for many cancers, but the pathogenesis underlying H...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jingyi Yuan, Kaixin Lei, Quanling Kong, Tao Chang, Xinhang Gu, Juan Wang, Li-na He, Jiadi Gan, Bojiang Chen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-09-01
Edice:	Frontiers in Oncology
Témata:	immune checkpoint inhibitor hypertension non-small cell lung cancer PD-1/PD-L1 inhibitors prognosis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1621363/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!